Group 1 - The Hong Kong stock market saw a strong opening in the pharmaceutical sector, with the Hang Seng Medical ETF (159506) rising by 5.09% and the Innovative Drug ETF (159748) increasing by 1.91% [1] - Notable performers included Zai Lab, which surged over 13%, while Kelun-Biotech, Genscript Biotech, and United Laboratories each rose by more than 6% [1] - The Ministry of Commerce and other departments released a plan to promote health consumption, encouraging retail pharmacies to expand their roles in health promotion and nutrition, and facilitating the smooth flow of electronic prescriptions in designated medical institutions [1] Group 2 - The Hang Seng Medical ETF (159506) closely tracks the Hang Seng Hong Kong Stock Connect Healthcare Index (HSSCHI), with a focus on companies with high R&D spending and innovative drug business, helping investors capture investment opportunities in the Hong Kong pharmaceutical sector [2]
超5%！港股医药高开领衔，恒生医疗ETF（159506）盘中涨幅达5.09%
Mei Ri Jing Ji Xin Wen·2025-04-14 02:04